服務熱線
021-60498804
| Cat. Number | G7444 |
| Chemical Name | G7444 GSK-1070916 942918-07-2 |
| CAS Number | 942918-07-2 |
| Mol. Formula | C30H33N7O |
| Mol. Weight | 507.63 |
| Qty 1 |
1mg |
| Qty 2 | 10mg |
| Appearance | Yellow to off white powder |
| Application Notes | ≥98% |
| Synonym | GSK1070916, NMI-900 |
| Solubility | DMSO 93 mg/mL (183.2 mM) Ethanol 8 mg/mL (15.75 mM) Water Insoluble |
| Storage condition | -20°C |
| References | GSK-1070916 is an inhibitor of aurora kinases B and C (AurB/C) that exhibits anticancer chemotherapeutic activity. GSK-1070916 prevents AurB from phosphorylating serine 10 of histone H3. In cellular and animal models of lung cancer, GSK-1070916 inhibits cellular proliferation and induces tumor regression. In models of colon cancer, breast cancer, and leukemia, this compound inhibits cell division, induces apoptosis, and suppresses tumor growth. ReferencesAdams ND, Adams JL, Burgess JL, et al. Discovery of GSK1070916, a potent and selective inhibitor of Aurora B/C kinase. J Med Chem. 2010 May 27;53(10):3973-4001. PMID: 20420387. Hardwicke MA, Oleykowski CA, Plant R, et al. GSK1070916, a potent Aurora B/C kinase inhibitor with broad antitumor activity in tissue culture cells and human tumor xenograft models. Mol Cancer Ther. 2009 Jul;8(7):1808-17. PMID: 19567821. |
Copyright ? 2022 上?；菡\生物科技有限公司
滬ICP備2021037845號-6
